Anti-Angiogenesis in Glioblastoma: The Clinical Consequences of Redundancy and Evasion?

E-ISSN： 2211-5536|2|2|126-134

ISSN： 2211-5528

Source： Current Angiogenesis, Vol.2, Iss.2, 2013-09, pp. : 126-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exosomes Function in Pro- and Anti-Angiogenesis

Current Angiogenesis, Vol. 2, Iss. 1, 2013-07 ,pp. : 54-59

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 88-96

Bentham Science Publishers

Access to resources Recommend Favorite

Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention (Review)

By Wang Ma Zheng

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 215-219

Spandidos Publications

Access to resources Recommend Favorite

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 60-65

Bentham Science Publishers

Access to resources Recommend Favorite

The Quest for Surrogate Markers of Angiogenesis: A Paradigm for Translational Research in Tumor Angiogenesis and Anti- Angiogenesis Trials

Current Molecular Medicine, Vol. 3, Iss. 8, 2003-12 ,pp. : 673-691

Bentham Science Publishers

Access to resources Recommend Favorite